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Obj ectives, The purpose of this study was to assess the effect of
the dual cyclooxylipoxygenase blocking agent BW7SSC on
the extent of myocardial infarction in the pig and to identify the
mechanism of any cardioprotective action of this drug .
Background. Activated neutrophils contribute to reperfusion
Injury after myocardial Infarction and inhibition of neutrophil
function can limit infarct size .
Mgt , in 9 control and 10 study pigs pretreated with
intravenous BW755C (10 mg/kg body weight) 30 min before
coronary occlusion, ischemia was Induced by a 50-min occlusion of
the odd-left anterior descending coronary artery, followed by 3 h
of reperfusion. Heart rate, arterial pressure, left ventricular
end-diastolic pressure, the first derivative of left ventricular
pressure (dP/dt) and regional myocardial blood flow were mea-
sured during control, occlusion and reperfuslon periods . Infarct
she was determined by histochemical staining ; and myeloperoxi-
activity, a marker for tissue neutrophil content, was assessed
in normal and Infareted
myocardium, The effect of BW7SSC on
the function of Isolated neutrophils stimulated with zy
activated serum was evaluated by measuring neutrophil degran .
Pt lymorphonuclear leukocytes have been implicated in the
cardiac dam produced during reperfusion after myocar-
dial infarction. Activated neutrophils may contribute to the
extension of infarction by a series of inflammatory pro-
cesses, including egation (1), trapping in the microcircu-
lation (2,3), migration (1,4) and release of cytotoxic products
(4). Inhibition of selective neutrophil functions by several
methods, including pharmacologic therapy (4-7), can de-
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ulation, leukotriene 134 production, superoxide generation and
chemotaxis.
Results. Hemodynamic function and regional myocardial blood
flow were similar in control and BW75SC-treated animals . BW755C
significantly red
	
myocardial infarct size compared with that In
control animals, as measured by in tlrisk areas by histochemical
staining (39 5% vs. 63 ± 7%, p < 0.05) . Myocardial roycloper.
oxi activity was similar in normal, salvaged and Infarcted areas
in the control and treated groups, Indicating that neutrophil accu-
mulation in Injured myocardium was unaltered by B 55C, How-
ever, agent attenuated function of Isolated, stimulated
activated serum) neutrophils. At a concentration of 0.03 mg/mI,
BW755C Inhibited deg ulation (-46%), leukotrlene 84 p uc-
(--48 ) and sum de generation (-74%), but there was
minimal Inhibition of ch in vitro.
Conclusions. These findings demonstrate that myocardial in-
farct size can be reduced by selective inhibition of neutrophil
cytotoxic activity without affecting neutrophil migration into
injured myocardium.
(J Am Call Cardiol 1993,22 :1738-44)
crease infarct size . The efficacy of BW755C, a dual cycloox-
ygenase-lipoxygenase blocking agent (8), in reducing the
extent of experimental myocardial infarct size (5,6) has been
related to its inhibitory effects on the proinflammatory
properties of neutrophils, such as aggregation (7), infiltration
into injured myocardium (6), superoxide generation (7) and
synthesis of eicosanoids from arachidonic acid (4,6,7) . How-
ever, studies in noncardiac tissue (9-11) have demonstrated
that BW755C and other lipoxygenase inhibitors can attenu-
ate lipoxygenase activity without decreasing the migration of
neutrophils to the site of inflammation . This finding suggests
the potential for a protective effect, even in the presence of
neutrophil accumulation, by a decrease in neutrophil-
generated cytoxic products .
Previous investigation of the cardioprotective effect of
BW755C is limited to two reports in the dog (5,6), neither of
which assessed the influence of the drug on regional myo-
cardial blood flow . Clarification of this variable is essential to
elucidating the p .-otective mechanism of an intervention
during myocardial infarction because regional myocardial
0735-10971931$6 .00
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perfusion during ischemia is dependent on collateral blood
flow. The native coronary collateral circulation of the dog is
a major factor that limits myocardial infarct size in this
species (12) in contrast to the pig (13), which, like humans
(14), has virtually no functional coronary collateral vessels in
the absence of chronic myocardial ischemia . Because the
functional and anatomic characteristics of the porcine native
coronary collateral circulation are similar to those of hu-
amm, the pig may provide a more suitable model than the
dog for assessment of interventions that limit infarct size .
Therefore, the purpose of this study was to assess 1) the
effect of BW755C on infarct size in the pig, a species in
which it has not been studied, and 2) the mechanisms of any
protective action of BW755C on extent of infarction .
Methods
Instrumentation. Adult male and female domestic pigs,
weighing 17 to 44 kg, were fnvanesthetized with intramus-
cular ketamine (20 mg/kg body weight), intramuscular atro-
pine (0.05 tag/kg) and intravenous sodium thiamylal
(10 mg/kg). Animals were intubated and ventilated with
positive pressure . After intubation, anesthesia was main-
tained with sodium thiamylal (10 to 20 mg/kg per h) .
The chest was opened by a midline sternotomy . The
electrocardiogram (ECG) was continuously monitored . Both
internal mammary veins were cannulated for administration
of anesthesia and drugs . An internal mammary artery was
cannulated for measurement of arterial pressure and for
blood sampling . Arterial blood gases were measured every
30 min and were maintained within physiologic limits . The
right carotid artery was cannulated with a 7F catheter-tipped
pressure transducer that was passed retrogradely into the
left ventricle. In nine pigs, catheters were introduced into
the left atrium and femoral artery for measurement of
regional myocardial blood flow by the radioactive micro-
sphere technique (15) . The pericardium was opened, and the
left anterior descending coronary artery was isolated .
Experimental protocol . The ECG, aortic blood pressure,
left ventricular pressure and the first derivative of left
ventricular pressure (dP/dt) were monitored continuously
and recorded at each measurement period . The heart rate-
blood pressure product, an index of myocardial oxygen
demand, was calculated by multiplying the left ventricular
systolic pressure and heart rate. After 20 min of stable
hemodynamic function, control data were recorded .
BW755C, solubilized in distilled water, was administered
intravenously to 10 pigs (10 mg/kg for 10 min) . Nine pigs
comprised the control group. Thirty minutes after adminis-
tration of BW755C, hemodynamic variables and the ECG
were recorded. Baseline regional myocardial blood flow was
measured by microsphere injection in a subgroup of five
control and four treated pigs . The left anterior descending
coronary artery was then occluded at its midpoint for 50 min
by a nontraumatic clamp . Hemodynamic data and the ECG
were recorded every 15 min during the period of occlusion .
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Coronary blood flow measurements were repeated at 5 and
45 min during the occlusion period . After 50 min the ocr
cluder was removed, and the left anterior descending coro-
nary artery was reperfused for 3 h, during which heroody-
namic data were recorded every 30 min . Blood flow
measurements were obtained at 45 and 175 min of reperfu-
sion .
Direct current countershock (30 J) was applied to the
epicardium (remote from the risk area) for sustained ventric-
ular tachyarrhythmias associated with severe hypotension .
If hemodynamic stability was not restored within 3 min, or if
more than two shocks were required, the animal was ex-
cluded from the study .
Measurement of infarct size . After 3 h of reperfusion, the
left anterior descending coronary artery was briefly reoc-
eluded at the original site of occlusion, and 60 ml of 0.5%
patent blue dye was ii jected into the left atrium to identify
the region of myocardium at risk (16) . The pigs were then
euthanized by ventricular fibrillation induced with electrical
current . Hearts were rapidly removed and rinsed, and the
left ventricle was sectioned into four to six transverse
sections, approximately I cm thick, from apex to base . The
slices were weighed and traced onto clear acetate sheets to
demarcate normal (blue stain) and risk areas (unstained) .
The slices were incubated at 37°C for 20 min in a 1% solution
of triphenyltetrazolium chloride (TTQ in 10 mmol/liter of
potassium phosphate buffer (pH 7 .4) and then retraced on
the original acetate sheets to demarcate the salvaged area
(16) (red stain, TTC positive) . The tracings were magnified
and scanned by computer to yield the risk and infarct areas
(infarct area is the unstained area within the risk area) as a
percent of slice weight, from which the estimated infarct and
risk areas were calculated .
Regional myocardial blood flow . Regional myocardial
blood flow was assessed by injecting approximately 3 X 100
15-Am (diameter) radiolabeled microspheres (scandium-46,
niobium-95, indium-114, ruthenium-103, tin-113, chromium-51,
cerium-141 or strontium-85) into t"e left atrium. Spheres were
suspended in 10% dextran and 0.01% Tween 80 solvent .
Reference blood samples were withdrawn from the femoral
artery and regional myocardial blood flow was calculated (15)
in sections of infarcted, salvaged and normal myocardium with
a germanium detector based gamma counter .
Myocardial myeloperoxidase activity . Se-v real tissue sam-
ples in each pig were excised from the control, salvage and
infarct areas of the myocardium and were frozen in liquid
nitrogen and stored at -45°C until assayed . Myeloperoxi-
dase activity was measured as described previously (17) .
One unit of mycloperoxidase activity was defined as that
degrading I mole of peroxide/min at 25°C . Assessment of
this assay with isolated porcine neutrophils demonstrated a
linear relation between myeloperoxidase and the number of
cells (r ® 0.92) in which I U of inyeloperoxidase activity
corresponded to 2 .9 x 10' neutrophils
Neutrophil isolation . Porcine neutrophils were isolated
from venous blood, as described elsewhere (18) . The prep-
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arations routinely contained >96% neutrophils with >95%
viability, as assessed by trypan blue exclusion .
Su xide anion generation .
Superoxide anion genera-
tion was measured by the superoxide dismutase-inhibitable
reduction of ferricytochrome c, according to Babior et al .
(1.9). Briefly, neutrophils (1.5 x 106
cells) were preincubated
at 37°C with ferricytochrome c (1 .25 mg/ml) in the presence
of cytochalasin B (5 µg/mp and
a total volume of I ml and
then stimulated with zymosan-activated serum (final concen-
tration 10%) for 20 min . The zymosan-activated serum was
prepared as previously described (20) . Separate aliquots
were preincubated with BW755C at a concentration of
0.03 mg/ml
. A duplicate set of tubes contained the same
reagents plus 60 U of superoxide dismutase . Superoxide
anion generation was determined spectrophotometrically at
550 nm by the difference in absorbance between the samples
with and without superoxide dismutase, utilizing an extinc-
tion coefficient of 21 . I mmol/liter - ° 1 . Results are expressed
as nmole O2- '/106 cells per 20 min .
Ref of leukotriene B4 . Neutrophils (10 x 10
6 cells/all)
were preincubated at 37°C with BW755C (0 .03 mg/ml) or
vehicle (banks' balanced salt solution) for 15 min. The cells
were subsequently stimulated by zymosan-activated serum
(10% final concentration) for 20 min in the presence of
cytochalasin B, and the reaction was terminated by centrif-
ugation at 2,500 g. The supernatants were assayed for
immunoreactive leukotriene B4 by radioimmunoassay kits,
as described elsewhere (17) .
ranulation of neutrophils . Neutrophils (10 x 106 cellsl
ml) were preincubated with cytochalasin B in the presence
and absence of BW755C (0 .03 mg/ml) or vehicle for 15 min .
The cells then were incubated for 20 min at 37°C with 10%
zymosan-activated serum . After;-ailing to 4°C and centrif-
ugation (2,500
g
for IS min), the cell-free supernatant was
mixed (I ;1) with I% hexadecyltrimethylammonium bromide
in 50 mmol/liter of potassium phosphate buffer at pH 6 .0
before sonication in an ice bath for lb F . Suspensions were
further centrifuged, and the resulting supernatants were
assayed for myeloperoxidase .
C' taxis. Neutrophils (0 .5 x l06/ml) were preincu-
bated for 15 min in vehicle or BW755C (0 .03 mg/ml) and
placed in the upper compartment of a modified Boyden
chamber (21) . The cells were separated from the bottom
compartment containing % zymosan-activated serum or
vehicle by a 1 .3-mm, 3 .0-µm polyvinyl pyrolidone-free poly-
carbonate filter and incubated for 30 min (5% carbon diox-
ide, W humidity, 37°C). The filters were then fixed and
stained. The number of cells migrating to the lower surface
was then counted in 10 high power (x400) fields, and the
results were averaged, In additional experiments, the lower
compartment was inspected to determine whether any cells
that had migrated through the filter had become nonadherent
and dropped off, falsely reducing the count of migrating
cells . Less than 5% of neutrophils were nonadherent in the
control and BW755C groups.
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Figure 1. Effect of BW755C on myocardial infarct size . Infarcied
area (IA) as a percent of risk area (RA) was significantly reduced
(p < 0.05) by BW755C. Percent of left ventricle (LV) at risk was
similar in the treated and control groups (control, n 9; BW755C,
n - 10) . Values are mean percent ± SCM .
Histopathology. Sections of myocardium were removed
from 'ITC-positive, TIC-negative and patent blue-stained
segments from control and BW75SC-treated pigs . The seg-
ments were embedded in paraffin, sectioned and stained with
hematoxylin-eosin and reviewed in a blinded manner by a
cardiovascular pathologist .
Data analysis. Data are presented as mean value ± SEM .
Differences between control and BW755C-treated groups
were analyzed by Student t test for unpaired data . Multiple
comparisons were analyzed by two-way repeated measures
analysis of variance . A Bonferroni test was applied to
differences that were significant . Differences were consid-
ered significant if p < 0.05 .
These experiments conform to the "Position of the Amer-
ican Heart Association on Research Animal Use" adopted
by the Association in November 1984 .
Results
Study group. Exclusions . All pigs surviving the full cor-
onary artery occlusion-reperfusion protocol were included in
the data analysis . Three control pigs were excluded because
of arrhythmic death during occlusion reperfusion . One
BW755C-treated pig was excluded because of technical
problems during the histochemical staining process . There-
fore. 9 pigs were included in the final control group and 10
pigs in the final treated group .
Arrhythmias. Ventricular tachyarrhythmia occurred dur-
ing occlusion-reperfusion in all pigs . Direct current counter-
shock was required in 4 of the initial 12 control pigs (2 during
occlusion, 2 during reperfusion) . Three of these died as a
result of the arrhythmia and were not included in the study .
Countershock was required during occlusion in one
BW755C-treated pig and was successful .
Myocardial infarct size. Infarct size (IA/RA, Fig . 1) was
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Figure 2. Hemodynamic data in control and treated (BW755C) pigs
during control (C), coronary occlusion and reperfusion periods .
bpm = beats/min ; dP/dt = first derivative of left ventricular pres-
sure; HR = heart rate ; LVEDP = left ventricular end-diastolic
pressure ; MAP = mean arterial pressure ; RPP = heart rate x left
ventricular systolic pressure . Values are mean value ± SEM . *p <
0.05 (control, n = 9 ; BW755C, n = 10) .
less (p < 0.05) in the BW755C-treated group (39 ± 5%) than
in the control group (63 ± 7%) . Risk area as a percent of total
left ventricular mass was similar in the two groups (Fig . 1) .
Histologic analysis demonstrated consistent agreement
with the staining methods . Myocardial segments stained
with patent blue were always normal in morphology . Sam-
ples identified as salvaged (TTC positive [red]) had no
Table 1 . Left Ventricular Transmural Blood Flow*
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abnormalities
or only minimal changes, and tissue identified
as infarcted (absence of TTC staining) had multiple features
of ischemic damage, including necrosis, hemorrhage, edema
and neutrophil infiltration
Hemodynamic function
. Hemodynamic data differed in
the control and BW755C-treated groups at only two points
(Fig . 2) . Mean arterial pressure was higher in the control pigs
at 30 min of reperfusion, and left ventricular end-diastolic
pressure was higher in the BW755C-treated pigs at 150 min
of reperfusion .
Regional myocardial blood flow . Regional myocardial
blood flow was similar in the risk areas (myocardial infarct +
salvage) in the control and BW755C-treated groups during
the control, occlusion and reperfusion periods (Table 1) .
These measurements documented equivalent flow in the
norinal and risk regions before occlusion, negligible flow
during occlusion and hyperemic perfusion after occlusion in
both groups of pigs .
Myocardial wyeloperoxidase activity. Myocardial myelo-
peroxidase activity increased significantly (p < 0 .05) in the
salvaged and infarcted left ventricular regions in both groups
(Fig . 3). The activity in the normal, salvaged and infarcted
areas did not differ between the two groups .
Neutrophil function. BW755C attenuated degranulation,
leukotriene
B4 release and superoxide generation by >40%
in response to stimulation with zymosan-activated serum
(Table 2). In contrast, BW755C had a minimal effect on
zymosan-activated serum-stimulated chemotaxis . BW755C
alone had no stimulatory effect on nelitrophils, nor did it
chemically interfere in any of the neutrophil assay systems
utilized .
Discussion
This study demonstrates that BW755C, a dual cyclooxy-
genase-lipoxygenase inhibitor, limits infarct size in the pig in
association with in vitro inhibition of several cytotoxic
neutrophil functions . Our results are unique in that, contrary
to previous findings with BW755C (5,6) and other anti-
inflammatory agents (4,7,22), this cardioprotective action
was not accompanied by a decrease in myocardial neutrophil
*There were no significant differences in transmural left ventricular blood flow between control and BW755C
groups in normal and risk regions . Values presented are mean value ±
SLM. NL
= normal left ventricular
myocardium :; Occl = occlusion of left anterior descending coronary artery
: RA = left ventricular risk area (infarct
and salvage) ; Reperf = reperfusion .
Pre-Occl
5-min
Occl
45-min
Occi
45-min
Reperf
175-min
Reperf
Control group (ml/g per min), n 5
NL 1.01±0 .14 1 .25±0.20 LW±IW
1 .07±0 .17 1A1 I 0A9
RA 0.90 ± 0A4 0A6 ± 0A2
0.04 ± 0 .02 1 .33 ± 0 .39 0.49 ± 0 .05
BW755c group (ml/g per min), n 4
NL
0.90±0 .05 0.96±0 .04 1.07±0 .02 1 .38±0
.29 1 .28±0 .18
RA 0A6 ± 0 .07 (( .0Z ± 0.01 0 .01 ± 0.01
1 .87 ± 0 .29 0.66 _~ 0 .10
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Figure 3. Myocardial myeloperoxidase (MPO) activity in control
and treated (BW?55C) pigs . Mycloperoxidase activity was increased
(p < 0,03) in the salvage and infarct regions of hearts in both groups,
but there were no significant differences in myeloperoxidase activity
between the groups in any of the respective myocardial regions
(normal, salvage or infarct) , wral, n - 9; BW755C, n
m
9) . Values
are mean value ± SEM .
accumulation, as reflected by mycloperoxidase activity .
Corresponding to this result in vv io, BW755C did not alter
neutrophil chemotaxis in vitro . BW755C did not influence
determinants of myocardial oxygen demand and supply,
indicating that its beneficial effect was related to other
factors. Our data suggest that this agent limited infarct size
in our experimental model by selective attenuation of neu-
trophil cytotoxic functions .
Although not all studies support the importance of neu-
trophOs in myocardial damage during infarction (23), there is
substantial evidence that they contribute to reperfusion
injury in acute myocardial infarction . In response to
chemoattractants, such as complement (4), leukotriene B4
(4,7) and oxidized plasma lipids (4), neutrophils undergo
directed migration into acutely injured myocardium, where
TAle 2. Effect of BW755C on Neutrophil Function After
Activation With Zymosan-Activated Serum
Vakms presented are mean value ± SEM for the number of experiments
indicated (n). HPFs
= high power fields
; LTB,, = leukotriene B,,
-, MPO
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they can induce injury by direct and indirect mechanisms
through release of proteolytic enzymes (6,7), oxygen-
derived free radicals (6,7), thromboxane A, (4), leukotrienes
(7) and oxidized fatty acids (4,6,7) .
Limitation of infarct size has been achieved experimen-
tally by inhibition of neutrophil activity through depletion of
neutrophils from peripheral blood (4,6) and treatment with
cyclooxygenase-lipoxygenase antagonists, such as BW755C
(5-7), nafazatrom (7) and piriprost (4) and by ibuprofen, an
anti-inflammatory drug that blocks only cyclooxygenase
(22) . These interventions all decrease neutrophil accumula-
tion in injured myocardium . In contrast to ibuprofen, cy-
clooxygenase inhibitors, such as indomcthacin (6), which do
not limit myocardial neutrophil deposition, have failed to
favorably modify myocardial infarct size . Ours is the only
study that demonstrates reduction of myocardial infarct size
by an anti-inflammatory agent without an associated de-
ci case in myocardial neutrophil infiltration. These data sug-
gest that recruitment of neutrophils during myocardial reper-
fusion may not be sufficient to augment tissue injury .
In vitro studies. In vitro tests of the effect of BW755C on
neutrophil function support our in vivo findings. The drug
exerted no effect on chemotactic activity of isolated neutro-
phils but substantially inhibited degranulation, superoxide
generation and leukotriene B4 release (Table 2) . Although
this selective inhibition of proinflammatory activity of neu-
trophils, in relation to cardioprotection has not been previ-
ously described with anti-inflammatory agents, similar find-
ings have been observed in noncardiac tissue in vitro (10,11)
and in vivo (9,10) . These studies have reported diminution of
inflammatory mediator release from neutrophils wiih little or
no effect by anti-inflammatory drugs, including BW755C, on
neutrophil migratory activity . Similarly, our findings suggest
that the protective mechanism of BW755C in our experimen-
tal model is related to suppression of neutrophil cytotoxic
activity .
We assessed myocardial neutrophil content by measure-
ment of tissue myeloperoxidase activity (24), which reflected
similarly increased neutrophil deposition in injured myocar-
dium in control and treated animals (Fig . 3) . The validity of
tissue myeloperoxidase activity as a measure of neutrophil
content is supported by our in vitro data demonstrating a
direct relation between myeloperoxidase activity and num-
ber of neutrophils and by concordance between myeloper-
oxidase activity and neutrophil count in infarcted myocar-
dium (24). Measurement of myocardial myeloperoxidase
activity has advantages over other techniques for quantitat-
ing neutrophils. Histologic determination is hindered by the
inhomogeneity of tissue neutrophil distribution and therefore
a large number of sections need to be examined for each
heart, an inefficient process that is only semiquantitative
(24) . Radioisotope-labeled neutrophils provide more quanti-
tative data, but the process of isolation, labeling and rein-
troduction of the cells to the circulation may substantially
alter their structural and functional integrity (25) .
Zymosaw
Activated
Serum
DW755C
(0 .03 mg/ml)
%
Inhibition
Chemotexis (no . of cellstl0
HPFs), n - 3
81,5±14 .5 78.4±16 .2 5
D"Melation (u61h of MM
activity), n ~ 3
0,13 t 0 .10 O'07-± 0 .10 46
LT84 production (ploy cells),
a M 2
140 ± 0.0 73.2 ± 8 .7 48
Superoxide generation (nmol
GY110"lls per 20 min),
18.4 ± 0 .2 4.8 ± 1 .5 74
n=3
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Comparison with previous studies . Our study includes
several important methodologic aspects that differentiate it
from previous investigations of BW755C in experimental
myocardial infarction . We utilized the pig rather than the
dog, which was used in the two previous reports of lh ,,! effect
of BW755C on extent of infarction (5 .6) . The pig, may be a
more relevant model for evaluating therapeutic interventions
in myocardial infarction . In addition to possessing three
main coronary vessels with right dominance in a majority,
humans and pigs have a paucity of coronary collateral
vessels in the absence of chronic ischemia (13,14) . The
relatively well developed innate coronary collateral circula-
tion of the dog at the onset of acute coronary occlusion is an
important determinant of myocardial infarct size in this
species (12) and provides a potential route through which
therapeutic agents might act . Left circumflex coronary ar-
tery blood flow measure(] by an electromagnetic flow trans-
ducer in a previous investigation (5) affords no insight into a
possible beneficial effect of the drug on coronary collateral
flow to the myocardial risk region . Our data exclude such an
effect because there was no evidence of augmented collateral
flow to the risk region of the treated group during coronary
occlusion or reperfusion .
The basis for the lack of an effect of BW755C on
myocardial neutrophil accumulation in our study, in contrast
to previous reports of dual cyclooxygenase-lipoxygenase
blockers (4,6,7), is unclear. The reduction of neutrophil
accumulation by these drugs in infarcted myocardium of
dogs (6,7) and rats (4) suggests that species differences may
be a factor. We utilized the same dose of BW755C used by
previous investigators (6,7) . Time of administration does not
appear to be a factor because these agents have reduced
neutrophil infiltration of myocardium when given before
coronary artery occlusion (6), as in our study, or after
occlusion (6,7) . BW755C has been associated with persis-
tence of neutrophil chemotaxis despite diminished produc-
,ion of leukotrienes (9-11), a finding that may be related to
other mechanisms that promote chemotaxis, such as com-
plement (4) and oxidized plasma lipids (4) .
Because platelet activation is important in the pathogen-
esis of myocardial infarction, we cannot exclude a role for
cyclooxygenase inhibition in the protective action of
BW755C . Platelets can contribute to ischemic cardiac injury
by microvascular aggregation (26), release of thromboxane
A2 (27) and through platelet-neutrophil interactions (4) .
These deleterious interactions can be inhibited by suppress-
ing thromboxane
A2
generation with cyclooxygenase block-
ade (27) and selective thromboxane
A2
synthetase inhibition
(28). However, BW755C has limited the extent of infarction
in the absence of a demonstrable platelet-inhibiting effect (5) .
It has also been reported that BW755C has antioxidant
properties (29), an action that could contribute to its cardio-
protective effect .
Study limitations . Several potential limitations of this
study must be considered . First, our conclusions with regard
to the mechanism of the cardioprotective effects of BW755C
AMSTERDAM ET AL
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are partially based on indirect evidence, an important elee
inent of which is our in vitro neutrophil data . Caution mw l
be exercised in extrapolating the in vitro effect of BW755C
on neutrophils to an in vivo action . The influence of the drug
on neutrophils in a pathophysiologic milieu may differ from
that occurring under isolated conditions in which the cells
are subjected to a single stimulus, such as zymosan-
activated serum
. Nevertheless, the in vitro results were
consistent with our findings in experimental infarction in that
BVV755C selectively inhibited neutrophil cytotoxic function
without altering chemotactic activity
. It is also possible that
intervention with BW755C could delay but not prevent
myocardial necrosis, as reported with flurbiprofen (30), or
apparent myocardial salvage could be an artifact of the
histochemical staining method (31) .
Conclusions. Our findings indicate for the first time that
BW755C, a dual inhibitor of lipoxygenase and cyclooxyge-
nase, reduces myocardial infarct size in the pig in association
with selective inhibition of neutrophil cytotoxic functions . In
contrast to previous studies with this and similar drugs, the
protective action did not involve decreased myocardial
infiltration of neutrophils, rather, it was associated with in
vitro reduction of degranulation, leukotriene B4 release and
superoxide generation .
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